Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.6K Hold
47
﹤0.01% 1683
2025
Q4
$25K Buy
47
+8
+21% +$4.52K ﹤0.01% 1653
2025
Q3
$19.5K Sell
39
-56
-59% -$27.1K ﹤0.01% 1733
2025
Q2
$45.3K Sell
95
-59
-38% -$26.1K ﹤0.01% 1628
2025
Q1
$56.5K Buy
154
+122
+381% +$46.7K ﹤0.01% 1854
2024
Q4
$12.9K Buy
32
+9
+39% +$4.39K ﹤0.01% 1936
2024
Q3
$11.6K Buy
+23
New +$10.7K ﹤0.01% 1778
2022
Q2
Sell
-14
Closed -$4K 2607
2022
Q1
$4K Buy
+14
New +$3.87K ﹤0.01% 2382
2020
Q4
Sell
-12
Closed -$2K 2900
2020
Q3
$2K Buy
+12
New +$2.59K ﹤0.01% 2387

Other funds holding CACI

Geneos Wealth Management's CACI Position: Q1 2026 in Review

Geneos Wealth Management held its CACI (CACI) position steady in Q1 2026 at 47 shares worth $25.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1683.

Geneos Wealth Management first reported a position in CACI in Q3 2020 and has held it in 9 quarters since. The position peaked at $56.5K in Q1 2025. 662 funds tracked by Wall St. Rank hold CACI as of Q1 2026.

  • Geneos Wealth Management held 47 shares of CACI worth $25.6K as of Q1 2026.
  • Geneos Wealth Management left its CACI share count unchanged in Q1 2026.
  • CACI made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1683 holding.
  • Geneos Wealth Management first reported a position in CACI in Q3 2020 and has held it in 9 quarters since.
  • Geneos Wealth Management's CACI position peaked at $56.5K in Q1 2025.
  • 662 funds tracked by Wall St. Rank held CACI as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.